Skip to content

Efficacy of Buffered Lidocaine in Patients With Facial Swelling

Anesthetic Efficacy of 4% Buffered Lidocaine in Emergency Patients With Facial Swelling.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01981772
Enrollment
88
Registered
2013-11-13
Start date
2013-03-31
Completion date
2014-06-30
Last updated
2020-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orofacial Swelling

Brief summary

The purpose of this study is to determine the clinical efficacy of a buffered 4% lidocaine solution for incision and drainage. Ninety patients will be examined clinically to determine a diagnosis of cellulitis or fluctuance. The diagnosis will be confirmed by incision and drainage. Patients will receive either 3.6 ml 4% lidocaine with 1:100,000 epinephrine or 3.6 ml 4% lidocaine with 1:100,000 epinephrine buffered with 8.4% sodium bicarbonate. Patients will rate pain prior to and throughout the procedure.

Detailed description

Incision and drainage of swellings is painful and anesthetic failure is common. One reason may be related to the lowered pH of inflamed tissue reducing the amount of the base form of anesthetic. A buffered anesthetic solution may result in more effective anesthesia than a non-buffered solution.

Interventions

DRUG4% lidocaine with 1:100,000 epinephrine

see arm/group description

DRUG4% buffered lidocaine with 1:100,000 epinephrine

see arm/group description

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 18 years or older * in good health (ASA classification I or II) * able to give informed consent * necrotic tooth with associated facial swelling

Exclusion criteria

* allergies to local anesthetics or sulfites * history of significant medical problems (ASA classification III or greater) * pregnancy * inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pain Measurement as Assessed on a Heft-Parker 170 mm Visual Analog Scaleduring incision/drainage on Day 0Patients will rate pain on a Heft-Parker visual analog scale during needle insertion, placement, and solution deposition phases of the anesthetic injection(s). Patients will also rate pain during the incision and dissection phases of the incision and drainage procedure. The number of millimeters along the scale are reported. No pain corresponded to 0 mm. Mild pain was defined as greater than 0 mm and less than or equal to 54 mm. Mild pain included the descriptors of faint, weak, and mild pain. Moderate pain was defined as greater than 54 mm and less than 114 mm and included the descriptor moderate. Severe pain was defined as equal to or greater than 114 mm up to and including 170 mm. Severe pain included the descriptors of strong, intense, and maximum possible.

Secondary

MeasureTime frameDescription
Postoperative Satisfaction on a 100 mm Visual Analog Scaleimmediately post-procedure on Day 0Patients will rate their level of satisfaction with the incision and drainage procedure using a visual analog scale. The scale ranges from not satisfied, to somewhat satisfied, to moderately satisfied, to completely satisfied. Not satisfied corresponded to 0 mm. Somewhat satisfied was defined as greater than 0 mm and less than or equal to 33 mm. Moderately satisfied was defined as greater than 33 mm and less than 66 mm. Completely satisfied was defined as equal to or greater than 66 mm. Measurements along the scale were collected and analyzed by randomization test.

Countries

United States

Participant flow

Participants by arm

ArmCount
Buffered Lidocaine
administration of 4% buffered lidocaine with 1:100,000 epinephrine 4% buffered lidocaine with 1:100,000 epinephrine
45
Nonbuffered Lidocaine
administration of 4% lidocaine with 1:100,000 epinephrine 4% lidocaine with 1:100,000 epinephrine
43
Total88

Baseline characteristics

CharacteristicNonbuffered LidocaineBuffered LidocaineTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
43 Participants45 Participants88 Participants
Age, Continuous36.3 years
STANDARD_DEVIATION 13.4
36.8 years
STANDARD_DEVIATION 13
36.55 years
STANDARD_DEVIATION 13.2
Region of Enrollment
United States
43 participants45 participants88 participants
Sex: Female, Male
Female
19 Participants19 Participants38 Participants
Sex: Female, Male
Male
24 Participants26 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 450 / 43
other
Total, other adverse events
0 / 450 / 43
serious
Total, serious adverse events
0 / 450 / 43

Outcome results

Primary

Pain Measurement as Assessed on a Heft-Parker 170 mm Visual Analog Scale

Patients will rate pain on a Heft-Parker visual analog scale during needle insertion, placement, and solution deposition phases of the anesthetic injection(s). Patients will also rate pain during the incision and dissection phases of the incision and drainage procedure. The number of millimeters along the scale are reported. No pain corresponded to 0 mm. Mild pain was defined as greater than 0 mm and less than or equal to 54 mm. Mild pain included the descriptors of faint, weak, and mild pain. Moderate pain was defined as greater than 54 mm and less than 114 mm and included the descriptor moderate. Severe pain was defined as equal to or greater than 114 mm up to and including 170 mm. Severe pain included the descriptors of strong, intense, and maximum possible.

Time frame: during incision/drainage on Day 0

ArmMeasureValue (MEAN)Dispersion
Buffered LidocainePain Measurement as Assessed on a Heft-Parker 170 mm Visual Analog Scale69.3 units on a scaleStandard Deviation 60.1
Nonbuffered LidocainePain Measurement as Assessed on a Heft-Parker 170 mm Visual Analog Scale59.2 units on a scaleStandard Deviation 50.5
Secondary

Postoperative Satisfaction on a 100 mm Visual Analog Scale

Patients will rate their level of satisfaction with the incision and drainage procedure using a visual analog scale. The scale ranges from not satisfied, to somewhat satisfied, to moderately satisfied, to completely satisfied. Not satisfied corresponded to 0 mm. Somewhat satisfied was defined as greater than 0 mm and less than or equal to 33 mm. Moderately satisfied was defined as greater than 33 mm and less than 66 mm. Completely satisfied was defined as equal to or greater than 66 mm. Measurements along the scale were collected and analyzed by randomization test.

Time frame: immediately post-procedure on Day 0

ArmMeasureValue (MEAN)Dispersion
Buffered LidocainePostoperative Satisfaction on a 100 mm Visual Analog Scale92.7 units on a scaleStandard Deviation 15.1
Nonbuffered LidocainePostoperative Satisfaction on a 100 mm Visual Analog Scale89.5 units on a scaleStandard Deviation 13.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026